SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001424884-14-000121
Filing Date
2014-11-19
Accepted
2014-11-19 16:56:10
Documents
9
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 tap10-q.htm 10-Q 619439
2 exhibit31-1.htm EX-31.1 13873
3 exhibit32-1.htm EX-32.1 5634
  Complete submission text file 0001424884-14-000121.txt   3178433

Data Files

Seq Description Document Type Size
4 tpiv-20140930.xml EX-101.INS 383944
5 tpiv-20140930.xsd EX-101.SCH 34601
6 tpiv-20140930_cal.xml EX-101.CAL 36693
7 tpiv-20140930_def.xml EX-101.DEF 98528
8 tpiv-20140930_lab.xml EX-101.LAB 221288
9 tpiv-20140930_pre.xml EX-101.PRE 180452
Mailing Address 1551 EASTLAKE AVENUE EAST, SUITE 100 SEATTLE WA 98102
Business Address 1551 EASTLAKE AVENUE EAST, SUITE 100 SEATTLE WA 98102 (206) 504-7278
TAPIMMUNE INC (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: NV | Fiscal Year End: 0220
Type: 10-Q | Act: 34 | File No.: 000-27239 | Film No.: 141236106
SIC: 2834 Pharmaceutical Preparations